肝病診斷市場規模、佔有率和成長分析：按產品類型、疾病類型、技術、最終用戶、應用、分銷管道和地區分類—2026-2033年行業預測

2024 年全球肝病診斷市場價值為 381 億美元，預計從 2025 年的 405.4 億美元成長到 2033 年的 665.9 億美元，預測期（2026-2033 年）複合年成長率為 6.4%。

全球肝病診斷市場成長的主要驅動力是與肥胖和METABOLIC INC.症候群相關的慢性肝病（尤其是非酒精性脂肪肝病）盛行率的不斷上升。日益成長的疾病負擔推動了對早期檢測工具的需求，包括用於診斷肝纖維化、脂肪肝、病毒性肝炎和肝細胞癌的檢測方法、影像技術和照護現場（PoC）系統。技術創新，特別是非侵入性分子診斷技術，正在促進患者篩檢和監測，從而實現快速轉診和早期療育。人工智慧的進步透過增強影像分析和整合臨床數據，提高了診斷準確性，從而帶來更一致的診斷結果。因此，對非侵入性且擴充性的工具（例如定量磁振造影平台和自動彈性成像系統）的需求日益成長，這些工具有助於及時發現和監測肝病。

全球肝病診斷市場按產品類型、疾病類型、技術、最終用戶、應用、分銷管道和地區進行細分。依產品類型分類，市場分為臨床實驗室、影像系統、切片檢查設備、分子診斷、照護現場診斷設備及其他。依疾病類型分類，市場包括肝炎、肝硬化、非酒精性脂肪肝病、肝癌、酒精性肝病及其他。按技術分類，市場包括免疫檢測、基於PCR的診斷、次世代定序、影像學、基於生物標記的診斷及其他。按最終用戶分類，市場包括醫院、診斷檢查室、專科診所、學術和研究機構及其他。按應用分類，市場分為疾病篩檢、疾病診斷、疾病監測和治療效果監測。依分銷通路分類，市場分為直銷、醫療設備批發商及線上銷售。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球肝病診斷市場成長要素

病毒性肝炎、非酒精性脂肪肝和各種慢性肝病的診斷數量不斷增加，推動了對可靠診斷解決方案的顯著需求。隨著醫療機構擴大篩檢範圍並採用更靈敏的檢測方法，市場對檢測設備、耗材和就地檢驗）的需求持續成長。此外，不斷擴大的患者群體促使製造商更加專注於開發新產品和加強分銷管道，從而有效彌補現有的診斷缺口。醫療生態系統中持續的創新和變革正在推動全球肝病診斷市場的持續成長，因為這些診斷工具在更廣泛的臨床應用中變得至關重要。

全球肝病診斷市場面臨的限制因素

先進診斷平台、專有試劑和專用耗材的高成本可能會阻礙小規模檢查室，尤其是資源有限的實驗室採用這些技術。這種經濟障礙可能導致市場滲透緩慢和檢查室停滯不前。當醫療預算緊張時，決策者更傾向於選擇成熟且成本較低的檢測方法，而不是投資新技術，從而導致舊設備更新延遲。此外，製造商和支付方在報銷框架和定價方面的分歧可能會延長採購流程，並最終削弱不同地區和不同類型醫療機構的投資動機。

全球肝病診斷市場趨勢

全球肝病診斷市場正經歷著向非侵入性診斷方法顯著轉變的趨勢，這反映了醫療產業日益重視改善患者體驗和簡化醫療流程的趨勢。醫療相關人員越來越重視基於血液的生物標記檢測和先進的影像學方案，這些方案有助於在專科醫療中心之外進行慢性病管理。這一趨勢不僅減少了侵入性檢查的需求，也簡化了轉診途徑，使基層醫療服務提供者能夠在疾病早期發現中發揮更積極的作用。因此，診斷開發商與醫療網路之間的合作得到加強，檢測演算法在常規實踐中的應用正在加速，大規模篩檢正在擴大，治療方案的發展也不斷最佳化。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球肝病診斷市場規模：依產品類型分類

• 臨床檢測
  • 肝功能檢查
  • 血液生物標記檢測
  • 病毒性肝炎檢測
  • 其他
• 影像系統
  • 超音波診斷設備
  • CT掃描儀
  • 磁振造影系統
  • 彈性成像系統
  • 其他
• 切片檢查裝置
• 分子診斷
• 即時診斷設備
• 其他

全球肝病診斷市場規模：依疾病類型分類

• 肝炎
• 肝硬化
• 非酒精性脂肪肝疾病
• 肝癌
• 酒精性肝臟疾病
• 其他

全球肝病診斷市場規模：依技術分類

• 免疫檢測
• 基於PCR的診斷
• 次世代定序
• 診斷影像
• 生物標記診斷
• 其他

全球肝病診斷市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 專科診所
• 學術研究機構
• 其他

全球肝病診斷市場規模：按應用領域分類

• 疾病篩檢
• 疾病診斷
• 疾病監測
• 治療反應監測

全球肝病診斷市場規模：按分銷管道分類

• 直銷
• 醫療設備批發商
• 線上銷售

全球肝病診斷市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Danaher Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN
• FUJIFILM Holdings
• GE HealthCare
• Philips Healthcare
• Canon Medical Systems
• Mindray Medical International
• Sysmex Corporation
• Randox Laboratories
• EKF Diagnostics
• Hologic
• Agilent Technologies
• PerkinElmer
• Merck KGaA
• Becton Dickinson

結論與建議

Global Liver Disease Diagnostics Market size was valued at USD 38.1 Billion in 2024 and is poised to grow from USD 40.54 Billion in 2025 to USD 66.59 Billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The growth of the global liver disease diagnostics market is primarily driven by the increasing prevalence of chronic liver conditions, particularly nonalcoholic fatty liver disease, linked to obesity and metabolic syndrome. This rising burden amplifies the demand for early detection tools, encompassing lab assays, imaging techniques, and point-of-care setups for diagnosing fibrosis, steatosis, viral hepatitis, and hepatocellular carcinoma. Technological innovations, particularly non-invasive molecular diagnostics, facilitate patient screening and monitoring, enabling quicker referrals and earlier interventions at hepatology centers. AI advancements enhance diagnostic accuracy through improved imaging analysis and integration of clinical data, leading to consistent outcomes. Consequently, there is an emerging demand for non-invasive, scalable tools, such as quantitative MRI platforms and automated elastography systems, promoting timely detection and monitoring of liver diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Liver Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Liver Disease Diagnostics Market Segments Analysis

The global liver disease diagnostics market is segmented by by product type, by disease type, by technology, by end user, by application, by distribution channel and region. Based on by product type, the market is segmented into Laboratory Tests, Imaging Systems, Biopsy Devices, Molecular Diagnostics, Point-of-care Diagnostic Devices and Others. Based on by disease type, the market is segmented into Hepatitis, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Liver Cancer, Alcoholic Liver Disease and Others. Based on by technology, the market is segmented into Immunoassays, PCR-based Diagnostics, Next-generation Sequencing, Imaging Diagnostics, Biomarker-based Diagnostics and Others. Based on by end user, the market is segmented into Hospitals, Diagnostic Laboratories, Specialty Clinics, Academic & Research Institutes and Others. Based on by application, the market is segmented into Disease Screening, Disease Diagnosis, Disease Monitoring and Treatment Response Monitoring. Based on by distribution channel, the market is segmented into Direct Sales, Medical Distributors and Online Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Liver Disease Diagnostics Market

The rise in diagnoses of viral hepatitis, nonalcoholic fatty liver disease, and various chronic liver conditions is driving a significant demand for reliable diagnostic solutions. As healthcare providers expand their screening initiatives and utilize more sensitive testing methods, the market is experiencing a consistent need for laboratory equipment, consumables, and point-of-care tests. Additionally, the increasing patient population encourages manufacturers to intensify their efforts in developing new products and enhancing distribution channels, effectively addressing existing diagnostic gaps. This ongoing innovation and adaptation within the healthcare ecosystem fosters sustained growth in the global liver disease diagnostics market, as these diagnostic tools become integral to broader clinical applications.

Restraints in the Global Liver Disease Diagnostics Market

High costs associated with advanced diagnostic platforms, proprietary reagents, and specialized consumables can deter smaller laboratories, particularly those in resource-constrained environments, from acquiring these technologies. This financial barrier can result in sluggish market penetration and stagnant adoption rates. When healthcare budgets face constraints, decision-makers are more likely to opt for established, lower-cost testing methods rather than invest in newer assays, leading to delays in upgrading outdated equipment. Additionally, disagreements between manufacturers and payers over reimbursement frameworks and pricing can prolong procurement processes, ultimately diminishing investment momentum in various regions and among different types of healthcare providers.

Market Trends of the Global Liver Disease Diagnostics Market

The Global Liver Disease Diagnostics market is witnessing a significant shift towards the adoption of noninvasive testing methods, reflecting a broader trend favoring enhanced patient experiences and streamlined care processes. Healthcare stakeholders are increasingly prioritizing blood-based biomarker panels and refined imaging protocols, which facilitate chronic disease management outside specialty centers. This growing preference not only reduces the need for invasive procedures but also simplifies referral pathways, enabling primary care providers to play a more active role in early disease recognition. Consequently, partnerships between diagnostic developers and healthcare networks are strengthening, accelerating the integration of testing algorithms into routine practice, expanding population screening, and optimizing treatment planning.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Liver Disease Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Laboratory Tests
  • Liver Function Tests
  • Blood Biomarker Tests
  • Viral Hepatitis Tests
  • Others
• Imaging Systems
  • Ultrasound Systems
  • CT Scanners
  • MRI Systems
  • Elastography Systems
  • Others
• Biopsy Devices
• Molecular Diagnostics
• Point-of-care Diagnostic Devices
• Others

Global Liver Disease Diagnostics Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Hepatitis
• Liver Cirrhosis
• Non-alcoholic Fatty Liver Disease
• Liver Cancer
• Alcoholic Liver Disease
• Others

Global Liver Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassays
• PCR-based Diagnostics
• Next-generation Sequencing
• Imaging Diagnostics
• Biomarker-based Diagnostics
• Others

Global Liver Disease Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Clinics
• Academic & Research Institutes
• Others

Global Liver Disease Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Screening
• Disease Diagnosis
• Disease Monitoring
• Treatment Response Monitoring

Global Liver Disease Diagnostics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Distributors
• Online Sales

Global Liver Disease Diagnostics Market Size & CAGR (2026-2033)

• North America (By Product Type, By Disease Type, By Technology, By End User, By Application, By Distribution Channel)
  • US
  • Canada
• Europe (By Product Type, By Disease Type, By Technology, By End User, By Application, By Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, By Disease Type, By Technology, By End User, By Application, By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Product Type, By Disease Type, By Technology, By End User, By Application, By Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Disease Type, By Technology, By End User, By Application, By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations